Back to Trades
Espinoza Octavio
Chief Financial OfficerCIK 0001905248
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 14
- Companies
- 1
- Active
- 2025–2026
Espinoza Octavio, Chief Financial Officer, has filed 11 SEC reports (2025–2026), all concentrated in LIGAND PHARMACEUTICALS INC (LGND), totaling $25.1M in disclosed volume. Weighing $0 bought versus $13.0M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Aug 14 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $9.2M |
| Jul 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $2.7K |
| May 28 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Exercise | $199.9K |
| Mar 27 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Grant | $4.8M |
| Mar 13 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $687.8K |
| Mar 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $2.8M |
| Feb 18 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Grant | $2.2M |
| Jan 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $765 |
| Dec 18 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Exercise | $328.6K |
| Dec 16 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $339.7K |
| Dec 9 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Tax withheld | $344.2K |
11 filings